跳至主要内容
临床试验/CTRI/2023/06/053881
CTRI/2023/06/053881已完成3 期

A Randomized Controlled Trial to assess the clinical and functional outcomes in patients of bhagandar (Transsphincteric anal fistula) using MIKST (Minimal invasive kshara sutra technique), LIFT (ligation of intersphincteric fistulous tract) and standard apamarg kshara sutra therapy

National institute of Ayurveda Amer Road Jaipur Rajasthan1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2023年1月7日最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
90
试验地点
1
主要终点
Primary Outcome Measures

研究概览

简要总结

Anal fistula is one of the most prevalent ailments in Ano-rectaldisease associated with long term impact and challenges encountered during its management. The prevalence is greater in men than women, with a rate of 12.3 cases per 100,000 and 5.6 cases per 100,000, respectively. Various emerging treatment modalities areavailable in Ayurvedic as well as contemporary science for fistula- in-ano but none proved to be ideal. Though comparative clinical trials are being done globally for anal fistula but drawback and limitations are associated with every intervention so we are not able to reach the final conclusion that which approach is best for the management of this perplexing disease.

Acharya Sushruta, the father of surgery and the author of Sushruta Samhita has mentioned Kshar Sutra therapy for the management of Bhagandar and it has already been incorporated as standard operating care for anal fistula with least chance of recurrence and incontinence. However, nowadays minimal invasive techniques are gaining more popularity due to its better patient compliance and outcome. Minimal invasive surgery continues to play an important role since it is efficient, safe and is convenient for surgeons as well as patients. MIKST is a novel sphincter saving technique which can yield treatment outcome with lesser duration as compared to conventional Kshar Sutra therapy.

Contemporary science also did a lot of work to propose an ideal treatment for anal fistula and LIFT (Ligation of Intersphincteric fistula tract) procedure is emerging as a good sphincter saving technique.Apart from LIFT, other interventions include fistulectomy, fistulotomy, anal fistula plug, fibrin or cyanoacrylate glue injection, endorectal advancement flap and video-assisted anal fistula treatment. All techniques carry some degree of incontinence and risk of recurrence.Few of these are difficult procedures to perform and require highly experienced surgeons or high-technology equipment. Therefore, here we have planned of this comparative study in Transsphincteric Anal fistula.

This study compares efficacy of all techniques on sameassessment parameters of the disease because till date no comparative study has been conducted using these three modalities i.e; MIKST, LIFT and Standard Apamarga Kshar Sutra therapy.

   NEED OF THE STUDY

Nowadays multiple innovative approaches available for the repair of anal fistulae but the best technique is not known and the available evidence suffers from a lack of high quality data with very few large RCTs. Considering tissue preservation and minimalinvasive method, current surgical practice lacks novel modality foranal fistula. Our Ayurveda science also actively contribute KsharSutra application for Bhagandar management in Sushruta Samhita and many studies also conducted in various institutions on this methodology but no any comparative data are available in contemporary as well as Ayurvedic science on these procedures i.e.MIKST, LIFT and Standard Apamarga Kshar Sutra therapy. After arrival of this data, maybe we will give better advise to our societyfor the management of this illness.

研究设计

研究类型
Interventional

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Patient clinically diagnose as a case of Transsphincteric Anal fistula in the age group of 18 years to 70 years of either sex.
  • Patient willing to participate in the study.
  • Patients with classical sign symptoms of Bhagandara (Pidika, Daha, Puya Srava).

排除标准

  • Patients with other systemic illnesses like uncontrolled Diabetes mellitus, Hypertension, Malignancy, Hepatitis B, Tuberculosis.
  • Infective and Neoplastic conditions of rectum, Rectal prolapse, Crohn’s disease.
  • Cases unfit and refused for surgery.
  • Patients having fistula in ano other than Transsphincteric type.

结局指标

主要结局

Primary Outcome Measures

时间窗: 12 MONTHS

1.Clinical healing of fistula in ano (No fistula opening & no fistula related symptoms on clinical examination & fistuloscopy) considering duration of complete healing in each arm.

时间窗: 12 MONTHS

3.Post-Operative complications (Late)

时间窗: 12 MONTHS

2.Post-Operative complications (Early)

时间窗: 12 MONTHS

•Pain (Through Visual Analogue Scale )

时间窗: 12 MONTHS

•Bleeding

时间窗: 12 MONTHS

•Itching

时间窗: 12 MONTHS

•Pus Discharge

时间窗: 12 MONTHS

•Stenosis (Through PASS)

时间窗: 12 MONTHS

•Incontinence (Through Wexner score)

时间窗: 12 MONTHS

•Recurrence

时间窗: 12 MONTHS

次要结局

  • •Hospital stay.(•Time to return to work.)

研究者

发起方
National institute of Ayurveda Amer Road Jaipur Rajasthan
申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验